atrial fibrillation

(redirected from Paroxysmal atrial fibrillation)
Also found in: Thesaurus, Medical, Acronyms, Encyclopedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.atrial fibrillation - fibrillation of the muscles of the atria of the heartatrial fibrillation - fibrillation of the muscles of the atria of the heart
arrhythmia, cardiac arrhythmia - an abnormal rate of muscle contractions in the heart
fibrillation - muscular twitching involving individual muscle fibers acting without coordination
fibrillazione atriale
References in periodicals archive ?
The lead product under development is an inhaled therapy intended to treat paroxysmal atrial fibrillation (PAF).
The results of the trial are anticipated to be used to back up an FDA regulatory submission for a paroxysmal atrial fibrillation indication.
Given the risk of complications with ablation, our data support the current guidelines recommending anti-arrhythmic drugs as first-line treatment in most patients with paroxysmal atrial fibrillation," wrote Dr.
Patients with stroke of unknown origin should have at least 21 days of MCOT monitoring to reliably detect paroxysmal atrial fibrillation in order to reduce their risk of future stroke," Miller said.
Zipes: Amiodarone is probably the most effective drug available to treat paroxysmal atrial fibrillation.
This was confirmed to be recurrent paroxysmal atrial fibrillation.
His medical history was significant for chronic obstructive pulmonary disease, blindness of unknown cause, paroxysmal atrial fibrillation, ischemic heart disease, congestive heart failure, and hepatitis B virus infection.
THERMOCOOL([R])Navigation Catheters are approved for drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with CARTO([R]) Systems (excluding NAVISTAR([R]) RMT THERMOCOOL Catheter).
InCarda's lead product in development consists of an established drug for paroxysmal atrial fibrillation (PAF) delivered in a novel way, via inhalation.
The company claims the device is the first therapeutic catheter approved in the United States that enables direct and real-time measurement of contact force during catheter ablation procedures for patients suffering from drug-resistant paroxysmal atrial fibrillation (AF or AFib), sustained monomorphic ischemic ventricular tachycardia and Type I atrial flutter.
BOSTON - Ablation bested antiarrhythmic drugs at reducing the incidence of time to first recurrence of atrial arrhythmias in patients with paroxysmal atrial fibrillation, results of a randomized, multicenter trial showed.